Medical/Pharmaceuticals
HeadaTerm 2: The Most Affordable FDA Cleared Innovative OTC Anti-Migraine Device
VANCOUVER, BC, April 2, 2024 /PRNewswire/ -- WAT Medical Enterprise achieves a major milestone: HeadaTerm 2 receives the OTC clearance from the U.S. Food and Drug Administration (FDA), making it one of the only wearable anti-migraine devices that is available without a prescription in the U.S. U...
Cognex Launches the World's First 3D Vision System with AI
AI-powered 3D vision system offers fast deployment and reliable inspections for manufacturing automation NATICK, Mass., April 2, 2024 /PRNewswire/ -- Cognex Corporation (NASDAQ: CGNX), the leader in industrial machine vision, today released the In-Sight® L38 3D Vision System, which combines AI, ...
China Medical University Hospital Develops "AISIA" to Diagnose Acute Ischemic Stroke in 90 Seconds to Assist Doctors in Making Medical Decisions
TAICHUNG, Taiwan , April 2, 2024 /PRNewswire/ -- The Neurology Department of China Medical University Hospital (CMUH,Taiwan), teaming up with AI Center at CMUH, has established the AISIA (Artificial Intelligence for Stroke Image Analysis) platform, which contains the "NCCT-based Ischemic Stroke D...
Innovating "Treadmill Exercise Test AI-Assisted Interpretation System," CMUH(Taiwan) Timely Saves More Patients with Severe Myocardial Infarction
TAICHUNG, Taiwan, April 2, 2024 /PRNewswire/ -- The treadmill exercise test (TET) is an important tool for diagnosing coronary artery disease (CAD), but limited by time spent for the manual interpretation of a dozen charts and the challenges in identifying minor deviations. Traditionally, manual ...
First Patient Dosed in Clinical Trial of YOLT-101 for the Treatment of FH
SHANGHAI, April 2, 2024 /PRNewswire/ -- YolTech Therapeutics announced that the first patient has been dosed with YOLT-101, the company'sin vivo genome editing candidate being developed as a single dose, potentially curative therapy for Familial Hypercholesterolemia(FH), marking the commencement ...
CONCEPT MEDICAL RECEIVES US FDA IDE APPROVAL FOR MAGICTOUCH AVF INDICATION, THEIR FIFTH US CLINICAL STUDY APPROVAL FOR THE MAGICTOUCH PORTFOLIO
TAMPA, Fla., April 2, 2024 /PRNewswire/ -- Concept Medical has been granted 'IDE Approval' from the U.S. Food and Drug Administration (FDA) for MagicTouch AVF, its Sirolimus drug-coated balloon (DCB) catheter, to initiate a clinical study for the treatment of stenotic lesions of Arteriovenous Fis...
Gushengtang Releases 2023 Annual Results: Sustained Growth with Robust Profit Increase
GUANGZHOU, China, April 2, 2024 /PRNewswire/ -- On March 27th, Gushengtang announced its financial results for 2023. During the year, the company's revenue reached2.323 billion yuan, marking a 43% year-over-year increase; the adjusted net profit was305 million yuan, increased by 53.6% compared to...
European Wellness Shines at AMWC 2024 in Monaco, with Prof. Dr Mike Chan and Prof. Dr Roni Moya as Faculty's Stem Cells Speakers
MONTE CARLO, Monaco, April 2, 2024 /PRNewswire/ -- The European Wellness Biomedical Group (EWBG), a global pioneer in biotechnology and bioregenerative medicine, is pleased to announce its extraordinary participation in the 22nd Aesthetic & Anti-Ageing Medicine World Congress (AMWC) 2024, which w...
Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Endometrial Cancer with Priority Review Status
ROCKVILLE, Md. and SUZHOU, China, April 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune,...
Fosun International: Total Revenue for 2023 Reached RMB198.2 billion, Industrial Operation Profit Increased by 20% YoY
HONG KONG and SHANGHAI, April 2, 2024 /PRNewswire/ -- Fosun International Limited (HKEX stock code: 00656, "Fosun International"), together with its subsidiaries ("Fosun" or the "Group"), today announced its annual results for the year ended31 December 2023 (the "Reporting Period"). During the R...
23WELL, THE health supplement brand on the watch
LOS ANGELES, April 1, 2024 /PRNewswire/ -- Just earlier last month, the highly anticipated Natural Products Expo West 2024 concluded successfully inAnaheim, CA. As one of the world's largest leading health and nutrition exhibition, it hosted more than 65,000 registered attendees and 3,000+ exhibi...
Oncoclínicas&Co has revenues of R$6 billion and profit of R$313 million in 2023
Increase in the number of patients treated and gains in operational efficiency explain record results SÃO PAULO, April 2, 2024 /PRNewswire/ -- Oncoclínicas&Co (B3: ONCO3) – the largest group dedicated to cancer treatment inLatin America – reported a 35.1% growth in its gross revenue in 2023, tot...
ThinkCyte advances biopharma phenotypic drug discovery programs with publication and presentation milestones
TOKYO, April 1, 2024 /PRNewswire/ -- ThinkCyte today announced the publication of apaper in the March issue of Cell Reports Methods on a new method for high-throughput drug discovery. Together with a joint research group including investigators at theUniversity of Tokyo and the University of Brit...
Lunit to Showcase 7 Studies at AACR 2024: Unveiling AI Innovations in HER2 Expression-Mutation Analysis and CNTN4 Biomarker Identification
- Lunit's AACR 2024 presentations to spotlight HER2 mutation insights and CNTN4's role in immunotherapy success, pioneering next-gen personalized treatment approaches, supported by the AI-powered Lunit SCOPE suite SEOUL, South Korea, April 1, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading...
Novel Immunogenicity Risk Assessment Platform, ISPRI, Facilitates Biologic Therapeutics Development
PROVIDENCE, R.I., April 1, 2024 /PRNewswire/ -- In the pursuit of developing novel biologic entities, scientists harnessing the power of AI and generative biology depend on computational tools for predicting and managing immunogenicity risk – a critical characterization step in the candidate dev...
Aculys Pharma Announces Appointment of Hidemasa Tanigaki as New CEO
~Hidemasa's appointment bolsters Aculys' position as a leader in the field of CNS inJapan and Asia~ TOKYO, April 1, 2024 /PRNewswire/ -- Aculys Pharma, Inc. ("Aculys"), a clinical-stage biopharmaceutical company focused on commercializing innovative treatments for neurological conditions, today ...
IMM CAREHUB - REDEFINING HEALTHY AGEING AND GERIATRIC REHABILITATION IN ASIA
KUALA LUMPUR, Malaysia, April 1, 2024 /PRNewswire/ --IMM Carehub, a pioneer in preventive care, healthy ageing, and geriatric rehabilitation, continues to make waves in the healthcare industry. AsMalaysia's First Lifestyle Rehab Centre for Seniors, IMM Carehub stands as a beacon of innovation and...
OFFICIAL LAUNCH OF THE NATIONAL UNIVERSITY SPINE INSTITUTE (NUSI): LEADING SPINE CARE INTO THE FUTURE
Public symposium by NUSI marks the end of a series of spine-related events that provide doctors with platform for professional development and networking SINGAPORE, March 30, 2024 /PRNewswire/ -- The National University Spine Institute (NUSI) is a new dedicated specialist spine institute under th...
CAIR-HK AI & Robotics Forum for Healthcare: Spotlight Interdisciplinary Integration of AI and Medicine
HONG KONG, March 29, 2024 /PRNewswire/ -- In this data-driven era, artificial intelligence and robotics technologies are rapidly reshaping people's lifestyles, with their profound impact in the field of medicine and healthcare becoming increasingly evident. From image-assisted diagnosis to intell...
Baird Medical Granted New Class III Certificate by China's NMPA for Ceramic Thyroid Ablation Needle
FRISCO, Texas, March 29, 2024 /PRNewswire/ -- Baird Medical Devices, Inc. ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider inChina and the United States, today announced it has been granted a new Class III certificate by the National ...
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 292 media titles]
2024-04-22 16:00Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 290 media titles]
2024-04-22 06:00With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 287 media titles]
2024-04-18 21:26China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25Animated Life in Yunnan
[Picked up by 281 media titles]
2024-04-18 14:00